Highly effective, well-tolerated, oral-only treatment for hepatitis C with direct-acting antiviral agents has been available for nearly a decade. Although curative treatment with DAAs is recommended for essentially everyone with hepatitis C, comprehensive hepatitis C testing and treatment in correctional settings has been challenged by various organizational, staffing, and budget constraints. This session presents strategies to advance hepatitis C elimination in correctional settings.

• Describe how hepatitis C testing and treatment in corrections advances national HCV elimination goals
• Discuss the most effective HCV screening policies and mechanisms to lower testing costs
• Examine approaches to treatment prioritization mechanisms to lower the cost of direct-acting antivirals

Level: Advanced